Matthew P. Ottmer

2016

In 2016, Matthew P. Ottmer earned a total compensation of $1.4M as Chief Operating Officer at Momenta Pharmaceuticals, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$252,281
Salary$450,000
Stock Awards$733,500
Other$13,091
Total$1,448,872

Ottmer received $733.5K in stock awards, accounting for 51% of the total pay in 2016.

Ottmer also received $252.3K in non-equity incentive plan, $450K in salary and $13.1K in other compensation.

Rankings

In 2016, Matthew P. Ottmer's compensation ranked 6,422nd out of 14,075 executives tracked by ExecPay. In other words, Ottmer earned more than 54.4% of executives.

ClassificationRankingPercentile
All
6,422
out of 14,075
54th
Division
Manufacturing
2,371
out of 5,486
57th
Major group
Chemicals And Allied Products
777
out of 1,900
59th
Industry group
Drugs
593
out of 1,543
62nd
Industry
Biological Products, Except Diagnostic Substances
109
out of 287
62nd
Source: SEC filing on April 27, 2017.

Ottmer's colleagues

We found five more compensation records of executives who worked with Matthew P. Ottmer at Momenta Pharmaceuticals in 2016.

2016

Craig Wheeler

Momenta Pharmaceuticals

Chief Executive Officer

2016

Scott Storer

Momenta Pharmaceuticals

Chief Financial Officer

2016

Ganesh Kaundinya

Momenta Pharmaceuticals

Chief Scientific Officer

2016

Bruce Leicher

Momenta Pharmaceuticals

General Counsel

2016

Richard Shea

Momenta Pharmaceuticals

Chief Financial Officer

You may also like